Norman David Eansor, President-Protein Sciences at BIO-TECHNE Corp (TECH), sold 46,374 shares at $268.41 ($12.4M) on 2020-05-22, disclosed to the SEC on 2020-05-26.
Open-market sale of $12.4M TECH by President-Protein Sciences. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $267.37 | 10,137 | $2.7M | 21.8% |
| 2 | $267.37 | 10,137 | $2.7M | 21.8% |
| 3 | $268.89 | 900 | $242K | 1.9% |
| 4 | $267.63 | 7,676 | $2.1M | 16.5% |
| 5 | $267.63 | 7,676 | $2.1M | 16.5% |
| 6 | $268.41 | 4,924 |
| $1.3M |
| 10.6% |
| 7 | $268.41 | 4,924 | $1.3M | 10.6% |
| Total | $267.71 avg | 46,374 | $12.4M | 100% |
| Filing → |
| TECH | SELL | 2021-09-02 | $1.5M | — | Filing → |
| TECH | SELL | 2021-02-09 | $17.4M | — | Filing → |
| TECH | SELL | 2020-06-01 | $4.1M | — | Filing → |